Keating Financial Advisory Services’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.7K Sell
624
-297
-32% -$26K 0.01% 662
2026
Q1
$83.3K Sell
921
-15
-2% -$1.38K 0.01% 502
2025
Q4
$84.2K Buy
+936
New +$88.8K 0.01% 540

Other funds holding ZBH

Keating Financial Advisory Services's ZBH Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its Zimmer Biomet (ZBH) stake by 32% in Q2 2026, selling an estimated $26K and leaving 624 shares worth $53.7K. The position accounts for 0.01% of the portfolio, ranked #662.

Keating Financial Advisory Services first reported a position in ZBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $84.2K in Q4 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Keating Financial Advisory Services held 624 shares of Zimmer Biomet worth $53.7K as of Q2 2026.
  • Keating Financial Advisory Services sold 297 Zimmer Biomet shares in Q2 2026, an estimated $26K.
  • Zimmer Biomet made up 0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #662 holding.
  • Keating Financial Advisory Services first reported a position in Zimmer Biomet in Q4 2025 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's Zimmer Biomet position peaked at $84.2K in Q4 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.